Side-by-side comparison
Semax vs Selank
Built from the published sections of each compound page. Empty cells mean that part hasn’t been published yet, not that there’s nothing to know.
Informational only. This doesn’t rank the two, recommend either, or suggest using them together.
Regulatory status
- Semax
- Research only (US)
- Selank
- Research only (US)
Class
- Semax
- Synthetic heptapeptide, ACTH(4-10) analogue
- Selank
- Synthetic heptapeptide, tuftsin analog
Half-life
- Semax
- Short (minutes plasma; effects last hours via receptor activation)
- Selank
- Short (minutes plasma)
Evidence
- Semax
- Not published yet
- Selank
- Not published yet
How it works
- Semax
- Not published yet
- Selank
- Not published yet
Research evidence
- Semax
- Not published yet
- Selank
- Not published yet
Side effects
- Semax
- Not published yet
- Selank
- Not published yet
Contraindications
- Semax
- Not published yet
- Selank
- Not published yet
Monitoring markers
- Semax
- Not published yet
- Selank
- Not published yet
Main uncertainties
- Semax
- Still in editorial review: quick overview, what it is, what researchers are studying, how it works.
- Selank
- Still in editorial review: quick overview, what it is, what researchers are studying, how it works.
Expert disagreements
- Semax
- Not published yet
- Selank
- Not published yet
Questions?
Send me a message and I’ll point you to the right guide or source.